Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Fujitsu PR and previous conversation analysis of Hawk conversation.

RE: Fujitsu PR and previous conversation analysis of Hawk conversation.

posted on Apr 18, 2006 02:59PM
You mean 46M? If 23M gets us .02/share....than 46M gets us .04/share. Not sure I follow your logic but at this point who knows? GLTA
Share
New Message
Please login to post a reply